Loading data
PRLBNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | 295.99 m USD | 277.69 m USD | 281.88 m USD | 272.93 m USD | 265.41 m USD |
| Gross profit | 237.14 m USD | 223.2 m USD | 221.99 m USD | 215.47 m USD | 222.69 m USD |
| Research and development expense | 42.81 m USD | 41.3 m USD | 40.14 m USD | 38.2 m USD | 44.2 m USD |
| Operating profit | 25.11 m USD | 19.91 m USD | 28.17 m USD | -97.98 m USD | 40.34 m USD |
| Profit before tax | 31.06 m USD | 24.67 m USD | 27.95 m USD | -97.88 m USD | 40.18 m USD |
| Income tax expense | 9.82 m USD | 8.1 m USD | 10.73 m USD | 5.59 m USD | 6.81 m USD |
| Net income (reported basis) | 21.24 m USD | 16.59 m USD | 17.22 m USD | -103.46 m USD | 33.37 m USD |
| Basic earnings per share | 0.89 USD/share | 0.66 USD/share | 0.66 USD/share | -3.77 USD/share | 1.21 USD/share |
| Diluted earnings per share | 0.88 USD/share | 0.66 USD/share | 0.66 USD/share | -3.77 USD/share | 1.21 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.